Clearmind Medicine Inc. (CMND) stock
CMNDNasdaqPharmaceutical PreparationsFiscal year ends October 31
Financials through Q3 FY2026, quarter ended Jul 31, 2026Score 5/30
$4.18−0.35 (-7.67%)
Close on Nov 16, 2026Market cap $661.18KP/E –Yield –
Clearmind Medicine cash
Cash and short-term investments held at the end of each period.
Clearmind Medicine's cash was $12.04M at Jul 31, 2026. For fiscal 2025 it was $3.92M, down 40.3% from the year before. The highest annual figure on record is $6.57M in fiscal 2024.
Annual cash
| Period | Period end | Value | Change |
|---|---|---|---|
| FY2025 | Oct 31, 2025 | $3.92M | -40.3% |
| FY2024 | Oct 31, 2024 | $6.57M | +21.1% |
| FY2023 | Oct 31, 2023 | $5.43M | +4114.8% |
| FY2022 | Oct 31, 2022 | $128.78K | -96.2% |
| FY2021 | Oct 31, 2021 | $3.37M | +1294.4% |
| FY2020 | Oct 31, 2020 | $241.66K | – |
Quarterly cash
Change is against the same quarter a year earlier.
Periods
| Period | Period end | Value | Change |
|---|---|---|---|
| Q3 FY2026CQ2 2026 | Jul 31, 2026 | $12.04M | +244.3% |
| Q2 FY2026CQ1 2026 | Apr 30, 2026 | $11.42M | +155.2% |
| Q1 FY2026CQ4 2025 | Jan 31, 2026 | $9.26M | +60.1% |
| Q4 FY2025CQ3 2025 | Oct 31, 2025 | $3.92M | -40.3% |
| Q3 FY2025CQ2 2025 | Jul 31, 2025 | $3.50M | -54.5% |
| Q2 FY2025CQ1 2025 | Apr 30, 2025 | $4.47M | -46.2% |
| Q1 FY2025CQ4 2024 | Jan 31, 2025 | $5.78M | -37.7% |
| Q4 FY2024CQ3 2024 | Oct 31, 2024 | $6.57M | +21.1% |
| Q3 FY2024CQ2 2024 | Jul 31, 2024 | $7.68M | +99.6% |
| Q2 FY2024CQ1 2024 | Apr 30, 2024 | $8.31M | +58.3% |
| Q1 FY2024CQ4 2023 | Jan 31, 2024 | $9.29M | +175.6% |
| Q4 FY2023CQ3 2023 | Oct 31, 2023 | $5.43M | +4114.8% |
| Q3 FY2023CQ2 2023 | Jul 31, 2023 | $3.85M | +14.2% |
| Q2 FY2023CQ1 2023 | Apr 30, 2023 | $5.25M | +2070.7% |
| Q1 FY2023CQ4 2022 | Jan 31, 2023 | $3.37M | – |
| Q4 FY2022CQ3 2022 | Oct 31, 2022 | $128.78K | – |
| Q4 FY2021CQ3 2021 | Oct 31, 2021 | $3.37M | – |
| Q4 FY2020CQ3 2020 | Oct 31, 2020 | $241.66K | – |
See a number that looks wrong?